MetaOptics Ltd Provides Update on Proposed Dual Listing on Nasdaq
Key Highlights for Investors
- Amended Registration Statement Filed: MetaOptics Ltd has filed an amended registration statement (Form F-1) with the U.S. SEC on 10 June 2026. This amendment reflects an updated number of American Depositary Shares (ADSs) to be offered in connection with the company’s proposed dual listing on the Nasdaq Stock Market.
- Underwriters Appointed: Roth Capital Partners and The Benchmark Company, LLC are acting as joint representatives of the underwriters for the proposed offering, signaling a step forward in the dual listing process.
- Offering Details Pending Effectiveness: The offering will only proceed once the registration statement becomes effective. As of now, no ADSs can be sold, and no offers to purchase can be accepted until this milestone is reached.
- Access to Preliminary Prospectus: Investors can review the preliminary prospectus on the SEC’s EDGAR platform or request copies directly from the underwriters.
- Shareholder Approval Secured: The company previously held an Extraordinary General Meeting (EGM) on 10 April 2026, where shareholders voted on the dual listing proposal, indicating formal shareholder engagement and consent for this strategic move.
- Regulatory Notice: The Singapore Exchange Securities Trading Limited (SGX-ST) has not examined or approved this announcement and takes no responsibility for its content.
Details and Potential Share Price Impacts
The announcement by MetaOptics Ltd is of significant importance to current and prospective shareholders, as the dual listing on Nasdaq represents a strategic initiative to broaden the company’s investor base, enhance trading liquidity, and increase global visibility. Such steps are often seen as positive catalysts for share price, subject to market conditions and investor sentiment.
The filing of the amended registration statement and the update on the number of ADSs to be offered are both price-sensitive events. Shareholders should closely monitor further announcements regarding the effectiveness of the registration statement and the final terms of the offering, as these will determine the timing and scope of MetaOptics Ltd’s Nasdaq debut.
The involvement of reputable underwriters (Roth Capital Partners and The Benchmark Company, LLC) adds credibility to the offering process and signals the company’s preparedness for the US capital markets.
Importantly, the company clarifies that no securities may be sold, nor offers to buy accepted, until the registration statement is declared effective by the SEC. Any potential investor or shareholder action should be based on official SEC filings and final prospectuses.
For further inquiries, shareholders are directed to the company’s investor relations contact at [email protected] or to the company’s sponsor, ZICO Capital Pte. Ltd.
What to Watch Next
- Effectiveness of the registration statement (expected to trigger the launch of the US offering).
- Final number of ADSs to be offered and offering price.
- Impact on share liquidity and valuation, both in Singapore and potentially in the US.
- Further disclosures from the company or regulatory bodies.
Disclaimer
This article is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities. No securities may be sold nor offers accepted prior to the effectiveness of the registration statement by the SEC. Investors are advised to review official filings and consult their financial advisors before making any investment decisions.
MetaOptics Ltd 纳斯达克双重上市最新进展
投资者需关注的要点
- 提交修订版注册声明：MetaOptics Ltd 于2026年6月10日向美国SEC提交了修订版F-1注册声明，内容包括更新将发行的美国存托股票（ADS）数量，为纳斯达克双重上市做好准备。
- 指定承销商：Roth Capital Partners和The Benchmark Company, LLC 被任命为此次发行的联合承销代表，显示公司推进上市进程的决心。
- 发行需待注册声明生效：只有在注册声明生效后，ADS发行才会正式启动。在此之前，无法出售ADS或接受购买要约。
- 预披露说明书获取方式：投资者可通过SEC的EDGAR平台查阅预披露说明书，或直接向承销商索取。
- 股东批准：公司已于2026年4月10日召开股东特别大会（EGM），并获得了股东对本次双重上市提案的批准，显示出公司治理的规范与合规。
- 监管声明：新加坡交易所（SGX-ST）未审查或批准本公告，其内容仅由公司负责。
细节与可能影响股价的因素
本次公告对现有及潜在股东具有重大意义，纳斯达克双重上市有望扩大公司投资者基础、提升股票流动性及国际知名度。此类举措通常被市场解读为利好，或对股价产生积极影响，具体还需视市场情绪和后续进展而定。
修订版注册声明的递交以及ADS发行数量的更新均属敏感信息，可能对股价产生影响。建议股东密切关注注册声明生效及最终发行条款的公布，这将决定MetaOptics在纳斯达克上市的时间表与规模。
著名承销商的参与进一步增强了本次发行的权威性，亦显示公司对美国资本市场的高度重视。
需特别注意，注册声明生效前，任何证券均不得出售，也不得接受购买要约。投资者应以SEC官方文件及最终说明书为准，审慎决策。
如需进一步咨询，可联系公司投资者关系邮箱 [email protected] 或公司赞助商ZICO Capital Pte. Ltd.
后续关注要点
- 注册声明何时生效（将触发美国市场发行）。
- 最终ADS发行数量及发行价。
- 股票流动性和估值变化，包括新加坡及美国市场。
- 公司或监管机构的进一步披露。
免责声明
本文仅供参考，不构成任何证券的销售要约或购买要约的邀请。在SEC注册声明生效前，任何证券不得出售，亦不得接受购买要约。投资者请以官方公告为准，并在作出投资决策前咨询专业理财顾问。
